Osimertinib Active Not Recruiting Phase 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Other

IndicationsStatusPurposePhase
Active Not RecruitingOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT02771314Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC